AIM To evaluate the effects of the dispersive viscoelastic agents Ocucoat (hydroxypropyl methylcellulose 2%) and Viscoat (sodium chondroitin sulphate 4%–sodium hyaluronate 3%) on postoperative intraocular pressure (IOP) after bilateral small incision cataract surgery.
METHODS This prospective, randomised study comprised 80 eyes of 40 consecutive patients with age related cataract in both eyes scheduled for bilateral small incision cataract surgery. The patients were randomly assigned to receive Ocucoat or Viscoat during cataract surgery of the first eye. The second eye was operated later and received the other viscoelastic agent. Cataract surgery was performed with a temporal 3.2 mm sutureless posterior limbal incision, phacoemulsification, and implantation of a foldable silicone intraocular lens. The IOP was measured preoperatively as well as 6 hours, 20–24 hours, and 1 week postoperatively.
RESULTS At 6 hours after surgery the mean IOP increased by 4.6 (SD 5.1) mm Hg in the Ocucoat group (p<0.001) and by 8.6 (8.1) mm Hg in the Viscoat group (p<0.001). The increase was significantly higher in the Viscoat group than in the Ocucoat group (p=0.004). Intraocular pressure spikes of 30 mm Hg or more occurred in two eyes in the Ocucoat and in nine eyes in the Viscoat group (p=0.023); 20–24 hours and 1 week postoperatively the mean IOP was not statistically different.
CONCLUSION These findings indicate that Viscoat causes a significantly higher IOP increase and significantly more IOP spikes than Ocucoat in the early period after small incision cataract surgery.
- cataract surgery
- intraocular pressure
Statistics from Altmetric.com
An increase in postoperative intraocular pressure (IOP) is a major postoperative complication within 24 hours after cataract surgery.1-3 Intraocular pressure spikes of 30 mm Hg or higher in the early period after cataract surgery may be associated with pain, corneal epithelial oedema, and damage of the optic disc, particularly in patients with glaucoma. This has become a concern, since an increasing number of cataract patients are operated in an outpatient setting and discharged shortly after cataract surgery. A main cause for the postoperative IOP increase is that the viscoelastic agent remains in the eye, which causes a mechanical obstruction of the trabecular meshwork.4
Ocucoat (hydroxypropyl methylcellulose) and Viscoat (sodium chondroitin sulphate–sodium hyaluronate) are dispersive viscoelastic agents with low viscosity at zero shear rate (Table 1). The dispersive nature causes better adherence of the viscoelastic agent to the corneal endothelium,5 possibly resulting in better protection of the corneal endothelium against fluid turbulence and lens fragments during phacoemulsification. This has led to frequent use of such dispersive viscoelastic agents in routine small incision cataract surgery. In the USA, among ASCRS members, Viscoat is used as viscoelastic agent in about 30%,6 and in Europe, among German language surgeons, Ocucoat or other hydroxypropyl methylcellulose preparations are used in about 45% of cataract surgeries.7
A potential drawback, however, is the difficulty of completely removing the dispersive viscoelastic agents at the end of surgery, possibly resulting in an increased postoperative IOP. For small incision phacoemulsification cataract surgery that currently is the most frequently performed technique, only one study reports on the effect of Viscoat,8 and there has been no study reporting the effect of Ocucoat on postoperative IOP.
We therefore conducted a prospective, randomised, patient and observer masked study to evaluate the effect of Ocucoat and Viscoat on postoperative IOP after bilateral small incision cataract surgery.
Patients and methods
This prospective randomised study comprised 80 eyes of 40 consecutive patients with bilateral age related cataract scheduled for small incision cataract surgery and implantation of an intraocular lens (IOL). The study protocol was approved by the ethics committee of the Vienna University School of Medicine. Written informed consent was obtained from all patients in the study. Exclusion criteria were previous ocular surgery, ocular hypertension (IOP higher than 22 mm Hg), and primary or secondary glaucoma. In each patient, the eye with the higher degree of cataract was operated first and randomly assigned to receive either Ocucoat (hydroxypropyl methylcellulose 2%, Storz Inc) or Viscoat (sodium chondroitin sulphate 4%–sodium hyaluronate 3%, Alcon Inc) during surgery. The second eye was operated later and received the other viscoelastic agent. No attempt was made to mask the surgeon since the viscoelastic substances have typical handling features. Both groups included 20 right and 20 left eyes. Twenty seven patients were women, 13 were men. The mean patient age was 75.9 (SD 9.3, range 54–92) years.
All patients were operated by the same surgeon (RM). Approximately 1–2 hours before surgery diclofenac, phenylephrine 2.5%, tropicamide 0.5%, and cyclopentolate 1% eye drops were instilled. After peribulbar anaesthesia was administered, a temporal single plane 3.2 mm posterior limbal incision was performed. The assigned viscoelastic agent (Ocucoat or Viscoat) was then injected into the anterior chamber. Capsulorhexis, hydrodissection, and phacoemulsification of the nucleus was followed by aspiration of the cortical remnants and bimanual cleaning of the capsular bag via three paracenteses. The capsular bag was then expanded with the assigned viscoelastic agent, and a foldable silicone three piece IOL was implanted in the capsular bag. The viscoelastic agent was aspirated thoroughly from the retrolental space, the capsule fornix, and the anterior chamber using an I/A tip. First, the proximal optic edge was tilted up with a spatula and the I/A tip inserted behind the optic. After the central portion of the viscoelastic substance was removed, the I/A tip was swept across and along the capsule equator to capture peripheral residuals. The I/A tip was then guided into the anterior chamber and the optic repositioned. While the aspiration opening was rotated right, left and posteriorly, the viscoelastic agent was circumferentially removed from the prelental as well as from the retroiridal and preiridal spaces. The surgeon was careful not to approach the delicate structures of the endothelium and the chamber angle too closely. Consequently, the residual film coating these structures was often observed to persist. Finally, the I/A tip was positioned on the centre of the optic and, while directing the aspiration opening upwards and pressing the tip down on the optic, the anterior chamber was rinsed before retracting the I/A tip. The incision was left sutureless. No miotic agent was used intracamerally, and no antiglaucomatous agent was instilled immediately after cataract surgery. Capsule rupture did not occur in any patient. After surgery, the eye was patched with prednisolone ointment. Treatment after the 20–24 hour visit consisted of diclofenac and prednisolone acetate 0.5% eye drops four times a day.
The baseline IOP was measured by Goldmann applanation tonometry on the day before surgery. The IOP was again measured with the same Goldmann applanation tonometer 6 and 20–24 hours after surgery. The ophthalmologist who measured the IOP was masked to the group assignment. If the IOP was 30 mm Hg or higher at the 6 hour visit, topical (dorzolamide, timolol, or both) or systemic (actetazolamide) antiglaucomatous agents were administered and the 20–24 hour IOP value was not used for statistical analysis. A routine follow up including IOP measurement was performed 1 week after surgery.
Group comparisons of the preoperative and postoperative IOP and of the mean IOP changes from preoperatively to 6 hours, 20–24 hours and 1 week postoperatively were made with paired ttests. Preoperative values were compared with those after 6 hours, 20–24 hours, and 1 week separately for each group, also using pairedt tests. The proportion of patients with an IOP of 30 mm Hg or higher was compared with the χ2 test. A p value <0.05 was considered statistically significant.
Table 2 shows the mean preoperative and postoperative IOP. There was no significant “between group” difference in preoperative IOP. At 6 hours postoperatively, the mean IOP was significantly higher in the Viscoat group than in the Ocucoat group. At 20–24 hours and at 1 week postoperatively, there was no significant between group difference.
Mean IOP changes from preoperatively to 6 hours, 20–24 hours, and 1 week postoperatively are listed in Table 3. At 6 hours, the mean IOP increased significantly in both groups. At 20–24 hours and at 1 week there was no significant change in either group.
Figure 1 compares the mean IOP changes in the two groups. At 6 hours, the mean IOP increase was significantly higher in the Viscoat than in the Ocucoat group (p=0.004). At 20–24 hours and at 1 week, there were no between group differences (p=0.662 and p=0.650, respectively).
Table 4 shows the number, percentage, and IOP in eyes with an IOP increase of 30 mm Hg or higher at 6 hours after surgery. There were significantly more eyes with an IOP increase of 30 mm Hg or higher in the Viscoat group than in the Ocucoat group. The highest IOP values were 48 mm Hg in the Viscoat group and 39 mm Hg in the Ocucoat group.
Viscoelastic agents are widely used in small incision cataract surgery. Their use has several advantages, and especially dispersive viscoelastic agents are thought to protect the corneal endothelium from extensive damage during the phacoemulsification procedure. However, viscoelastic agents have the disadvantage of causing an increase in IOP. This has become a major concern, since an increasing number of cataract surgeries is performed on an outpatient basis and patients are often discharged shortly after surgery. In this study, we evaluated the effect of two commonly used dispersive viscoelastic agents on the IOP after small incision cataract surgery.
Our findings indicate that in the early postoperative period after small incision cataract surgery, Viscoat causes a significantly higher IOP increase and significantly more IOP spikes than Ocucoat. At 6 hours postoperatively, the mean IOP increased by about 9 mm Hg in the Viscoat group and by about 5 mm Hg in the Ocucoat group. IOP spikes of 30 mm Hg or higher occurred in nine eyes in the Viscoat group compared with two eyes in the Ocucoat group. At 20–24 hours the mean IOP decreased to preoperative values in both groups. However, in this study no IOP lowering medication was given at the end of surgery. The fact that both viscoelastic agents caused a significant IOP increase and IOP spikes of 30 mm Hg or more, argues for a prophylactic use of IOP lowering medication.
In a previous study8 we compared the effect of Healon5, a cohesive viscoelastic agent, and Viscoat on postoperative IOP after small incision cataract surgery which was performed by the same surgeon (RM). At 6 hours postoperatively, the IOP increase was about 10 mm Hg in the Viscoat group which is comparable with the result of the present study. There has been no other report on postoperative IOP after small incision cataract surgery with Viscoat.
Moreover, there has been no report on postoperative IOP after small incision cataract surgery with Ocucoat. The postoperative IOP increase of about 5 mm Hg at 6 hours postoperatively with Ocucoat seems to be similar to that of Healon (sodium hyaluronate 1%)9 and Healon5 (sodium hyaluronate 2.3%).8
Articles reporting the effect of Viscoat or Ocucoat on postoperative IOP used manual extracapsular cataract extraction (ECCE)10-16 or phacoemulsification cataract surgery with a 7 mm incision.317 In two further studies antiglaucomatous agents were used and the IOP was measured at 1 day postoperatively only.1819 However, these reports are difficult to compare and often contradictory, since the postoperative IOP varies interindividually and with the surgical technique.
The mechanism of postoperative IOP increase is not yet fully understood. A major reason for the postoperative IOP increase seems to be the amount of the remaining viscoelastic agent at the end of surgery. It is assumed that the remaining viscoelastic agent mechanically obstructs the trabecular outflow pathway and hence decreases the outflow facility.4 In order to avoid a postoperative IOP increase, a thorough removal of viscoelastic agent is vital. Surgical techniques for the removal of viscoelastic substances, especially from behind the IOL, have been described,20-22but a complete prevention of a postoperative IOP increase could not be achieved with any technique.
In our study, both Ocucoat and Viscoat were equally removed with great care from the anterior chamber as well as from behind the IOL at the end of the surgery. However, it was nearly impossible to completely remove both viscoelastic agents without injuring the endothelium and other vulnerable structures of the eye. Assuming that the amounts of the remaining viscoelastic substances were similar in our study, the difference in postoperative IOP increase between the two viscoelastic agents might be explained by differences in their biophysical properties. The clearance of the viscoelastic agent through the trabecular meshwork is believed to be dependent upon the viscosity and molecular weight of the used materials.11 Theoretically, the lower the viscosity and the molecular weight of the viscoelastic agent, the faster is the clearance through the trabecular meshwork. In accordance with this theory, in our study Ocucoat which is less viscous and has a lower molecular weight than Viscoat caused less IOP increase. The lower viscosity of Ocucoat compared with Viscoat, may, however, have the disadvantage of poorer endothelial cell protection.
In conclusion, our study shows that in the early postoperative period after small incision cataract surgery Viscoat caused a significantly higher IOP increase and significantly more IOP spikes than Ocucoat. Although the viscoelastic agents were removed thoroughly, both Ocucoat and Viscoat caused a significant IOP increase compared with the preoperative IOP. Therefore IOP monitoring is necessary after small incision cataract surgery, and the use of IOP lowering medications is recommended, particularly in patients with compromised optic discs.
None of the authors has a proprietary interest in any product mentioned.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.